Link Health Group:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Link Health Group - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11337
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Link Health Group (Link Health) is a pharmaceutical company focused on the discovery and development of novel drug candidates for the treatment of cancer and other diseases. Its pipeline product portfolio includes LH011, an oral small molecule serine protease inhibitor for treating pancreatic and breast cancer; LH021 for cartilage repair; LH025, an anti-inflammatory tripeptide used for the treatments of inflammatory bowel disease as well as psoriasis; LH031, a novel small molecule inhibitor of the kinesin motor protein targeting lung and liver cancers; LH026 against Rhinitis. The company has operations with subsidiaries in China and Hong Kong. Link Health is headquartered in Guangzhou, China.

Link Health Group – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Link Health Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Link Health Group, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Link Health Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Link Health Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Link Health Group, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Link Health Group, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Link Health Raises USD8.85 Million in Series A Financing 10
Link Health Raises Funds through Venture Financing 11
Partnerships 12
Link Health Enters into Agreement with Shenzhen JYMed Tech 12
Licensing Agreements 13
Link Health Enters into Licensing Agreement with Teikoku Pharma 13
Link Health Enters into Licensing Agreement with 4SC 14
Link Health Enters into Licensing Agreement with Dr. Wolff Gruppe 15
Wilex Enters Into Licensing Agreement With Link Health For Mesupron 16
Link Health Group – Key Competitors 17
Link Health Group – Key Employees 18
Link Health Group – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Link Health Group, Pharmaceuticals & Healthcare, Key Facts 2
Link Health Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Link Health Group, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Link Health Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Link Health Group, Deals By Therapy Area, 2012 to YTD 2018 8
Link Health Group, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Link Health Raises USD8.85 Million in Series A Financing 10
Link Health Raises Funds through Venture Financing 11
Link Health Enters into Agreement with Shenzhen JYMed Tech 12
Link Health Enters into Licensing Agreement with Teikoku Pharma 13
Link Health Enters into Licensing Agreement with 4SC 14
Link Health Enters into Licensing Agreement with Dr. Wolff Gruppe 15
Wilex Enters Into Licensing Agreement With Link Health For Mesupron 16
Link Health Group, Key Competitors 17
Link Health Group, Key Employees 18
Link Health Group, Subsidiaries 19

List of Figures
Link Health Group, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Link Health Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Link Health Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Link Health Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Link Health Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Link Health Group, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Link Health Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Link Health Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Link Health Group:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Centene Corp (CNC)-製薬・医療分野:企業M&A・提携分析
    Summary Centene Corp (Centene) is a healthcare service provider that offers services to government sponsored healthcare programs with focus on under-insured and uninsured individuals. It provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts; and other health sol …
  • Chicago Bridge & Iron Company N.V.:企業の戦略・SWOT・財務情報
    Chicago Bridge & Iron Company N.V. - Strategy, SWOT and Corporate Finance Report Summary Chicago Bridge & Iron Company N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Investment Technology Group, Inc.
    Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Viveve Medical Inc (VIVE):医療機器:M&Aディール及び事業提携情報
    Summary Viveve Medical Inc (Viveve Medical), formerly PLC Systems Inc, is a medical device company that develops women’s health and wellness treatment solutions. The company offers non-prescription device to treat incontinence pelvic floor muscles, overactive detrusor muscle, urinary incontinence, O …
  • Public Bank Berhad:戦略・SWOT・企業財務分析
    Public Bank Berhad - Strategy, SWOT and Corporate Finance Report Summary Public Bank Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Median Technologies SA (ALMDT):企業の財務・戦略的SWOT分析
    Summary Median Technologies SA (Median) is a medical technology company that develops and markets medical imaging solutions. The company offers clinical trials, imaging services for CT, scientific consulting, image and clinical data management, image data processing and site support, managed service …
  • CAB Incorporated:企業の戦略的SWOT分析
    CAB Incorporated - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Hanwha Corp (000880):企業の財務・戦略的SWOT分析
    Hanwha Corp (000880) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Fraport Slovenija, d.o.o.:企業の戦略・SWOT・財務情報
    Fraport Slovenija, d.o.o. - Strategy, SWOT and Corporate Finance Report Summary Fraport Slovenija, d.o.o. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Pakistan Petroleum Ltd (PPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Pakistan Petroleum Ltd (PPL) is an upstream oil and gas company. It explores, develops and produces crude oil and natural gas resources. The company operates producing fields at Sui, Kandhkot, Adhi, Mazarani, Chachar, Adam, Adam West, Shahdadpur, Shahdadpur East and West. It also has working …
  • Simons Group Ltd:企業の戦略・SWOT・財務情報
    Simons Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Simons Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd:企業の戦略的SWOT分析
    The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employee …
  • National Bank of Greece SA:企業の戦略・SWOT・財務情報
    National Bank of Greece SA - Strategy, SWOT and Corporate Finance Report Summary National Bank of Greece SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Cintas Corporation:企業の戦略・SWOT・財務情報
    Cintas Corporation - Strategy, SWOT and Corporate Finance Report Summary Cintas Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Crane Co (CR):企業の財務・戦略的SWOT分析
    Crane Co (CR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Denka Co Ltd (4061):企業の財務・戦略的SWOT分析
    Denka Co Ltd (4061) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • FDC Ltd (FDC):企業の財務・戦略的SWOT分析
    Summary FDC Ltd (FDC) is a pharmaceutical company that manufactures and markets of oral rehydration salts, ophthalmics and functional foods. The company also provides active pharmaceuticals ingredients (APIs). It provides products for the therapeutic segments of anti-infectives, gastrointestinals, o …
  • Avenue Therapeutics Inc (ATXI):製薬・医療:M&Aディール及び事業提携情報
    Summary Avenue Therapeutics Inc (Avenue Therapeutics), a subsidiary of Fortress Biotech Inc, is a specialty pharmaceutical company that focuses on the development and commercialization of an intravenous (IV) tramadol for the management of severe postoperative pain in adults. The company’s IV Tramado …
  • Vilniaus Degtine AB:企業の戦略・SWOT・財務情報
    Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report Summary Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Trimedyne Inc:企業の戦略的SWOT分析
    Trimedyne Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆